Cargando…
Molecular basis of quercetin as a plausible common denominator of macrophage-cholesterol-fenofibrate dependent potential COVID-19 treatment axis
The world's largest randomized control trial against COVID-19 using remdesivir, hydroxychloroquine, lopinavir and interferon-β1a appeared to have little or no effect on hospitalized COVID-19 patients. This has again led to search for alternate re-purposed drugs and/or effective “add-on” nutriti...
Autores principales: | Pawar, Anil, Pal, Amit, Goswami, Kalyan, Squitti, Rosanna, Rongiolettie, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196513/ https://www.ncbi.nlm.nih.gov/pubmed/34150487 http://dx.doi.org/10.1016/j.rechem.2021.100148 |
Ejemplares similares
-
Zinc and COVID-19: Basis of Current Clinical Trials
por: Pal, Amit, et al.
Publicado: (2020) -
Microglia and Astrocytes in Alzheimer’s Disease in the Context of the Aberrant Copper Homeostasis Hypothesis
por: Pal, Amit, et al.
Publicado: (2021) -
Endosomal Cholesterol in Viral Infections – A Common Denominator?
por: Glitscher, Mirco, et al.
Publicado: (2021) -
Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update
por: Pal, Amit, et al.
Publicado: (2020) -
Medicare's Common Denominator: The Covered Population
por: Hatten, James
Publicado: (1980)